Charles River Laboratories International, Inc. Stock
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
223.1 USD | +0.65% | -2.34% | -5.64% |
Financials (USD)
Sales 2024 * | 4.22B | Sales 2025 * | 4.53B | Capitalization | 11.42B |
---|---|---|---|---|---|
Net income 2024 * | 406M | Net income 2025 * | 513M | EV / Sales 2024 * | 3.17 x |
Net Debt 2024 * | 1.94B | Net Debt 2025 * | 1.46B | EV / Sales 2025 * | 2.84 x |
P/E ratio 2024 * |
28.2
x | P/E ratio 2025 * |
22.8
x | Employees | 21,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.93% |
Latest transcript on Charles River Laboratories International, Inc.
1 day | +0.65% | ||
1 week | -2.34% | ||
Current month | -2.59% | ||
1 month | -1.64% | ||
3 months | -6.65% | ||
6 months | +17.07% | ||
Current year | -5.64% |
Managers | Title | Age | Since |
---|---|---|---|
James Foster
CEO | Chief Executive Officer | 73 | 75-12-31 |
Flavia Pease
DFI | Director of Finance/CFO | 51 | 22-04-24 |
Birgit Girshick
COO | Chief Operating Officer | 54 | 89-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Massaro
BRD | Director/Board Member | 76 | 02-12-31 |
Virginia Wilson
BRD | Director/Board Member | 68 | 19-09-30 |
Robert Bertolini
BRD | Director/Board Member | 61 | 11-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.05% | 1 M€ | +0.15% | - | |
2.07% | 5 M€ | -1.80% | - | |
1.08% | 0 M€ | 0.00% | - | |
0.98% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 223.1 | +0.65% | 473,731 |
24-05-17 | 221.6 | -1.40% | 927,644 |
24-05-16 | 224.8 | -3.36% | 1,301,402 |
24-05-15 | 232.6 | -0.11% | 529,498 |
24-05-14 | 232.8 | +1.93% | 502,307 |
Delayed Quote Nyse, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.64% | 11.42B | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- CRL Stock